Objectives: How do providers of artificial intelligence (AI) solutions propose and legitimize the values of their solutions for supporting diagnostic radiology workflow?
Methods: We systematically analyze 393 AI applications developed for supporting diagnostic radiology workflow. We collected qualitative and quantitative data by analyzing around 1250 pages of documents retrieved from companies' websites and legal documents. Five investigators read and interpreted collected data, extracted the features and functionalities of the AI applications, and finally entered them into an excel file for identifying the patterns.
Results: Over the last 2 years, we see an increase in the number of AI applications (43%) and number of companies offering them (34%), as well as their average age (45%). Companies claim various value propositions related to increasing the "efficiency" of radiology work (18%)-e.g., via reducing the time and cost of performing tasks and reducing the work pressure-and "quality" of offering medical services (31%)-e.g., via enhancing the quality of clinical decisions and enhancing the quality of patient care, or both of them (28%). To legitimize and support their value propositions, the companies use multiple strategies simultaneously, particularly by seeking legal approvals (72%), promoting their partnership with medical and academic institutions (75%), highlighting the expertise of their teams (56%), and showcasing examples of implementing their solutions in practice (53%).
Conclusions: Although providers of AI applications claim a wide range of value propositions, they often provide limited evidence to show how their solutions deliver such systematic values in clinical practice.
Key Points: • AI applications in radiology continue to grow in number and diversity. • Companies offering AI applications claim various value propositions and use multiple ways to legitimize these propositions. • Systematic scientific evidence showing the actual effectiveness of AI applications in clinical context is limited.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889424 | PMC |
http://dx.doi.org/10.1007/s00330-022-09090-x | DOI Listing |
JMIR Form Res
January 2025
Smith School of Business, Queen's University, Kingston, ON, Canada.
Background: Depression significantly impacts an individual's thoughts, emotions, behaviors, and moods; this prevalent mental health condition affects millions globally. Traditional approaches to detecting and treating depression rely on questionnaires and personal interviews, which can be time consuming and potentially inefficient. As social media has permanently shifted the pattern of our daily communications, social media postings can offer new perspectives in understanding mental illness in individuals because they provide an unbiased exploration of their language use and behavioral patterns.
View Article and Find Full Text PDFInteract J Med Res
January 2025
Department of Nursing Science, Diagnostics in Healthcare and eHealth, Trier University, Trier, Germany.
Background: Psychoeducation positively influences the psychological components of chronic low back pain (CLBP) in conventional treatments. The digitalization of health care has led to the discussion of virtual reality (VR) interventions. However, CLBP treatments in VR have some limitations due to full immersion.
View Article and Find Full Text PDFGac Med Mex
January 2025
School of Medicine, Pontificia Universidad Javeriana.
Background: In Colombia, gastric cancer is fifth in incidence (12.8 cases per 100,000) and third in mortality (9.9 cases per 100,000).
View Article and Find Full Text PDFGac Med Mex
January 2025
Laboratorio de Reprogramación Celular y Enfermedades Crónico-Degenerativas, Department of Physiology, Universidad Nacional Autónoma de México, Mexico City, Mexico.
Progressive supranuclear palsy (PSP) is a rare, atypical parkinsonism, characterized by the presence of intracerebral tau protein aggregates and determined by a wide spectrum of clinical features. The definitive diagnosis is postmortem and is identified through the presence of neuronal death, gliosis, and aggregates of the tau protein presented in the form of neurofibrillary tangles (MNF) with a globose appearance in regions such as the subthalamic nucleus, the substantia nigra, and the globus pallidus The findings in ancillary imaging studies, as well as fluids biomarkers, are not sufficient to support diagnosis of PSP but are used to rule out similar pathologies because there are still no specific or validated biomarkers for this disease. The current treatment of PSP is focused on reducing symptoms, although emerging therapies seek to counteract its pathophysiological mechanisms.
View Article and Find Full Text PDFJ Infect Dev Ctries
December 2024
Department of Veterinary Medicine, Faculty of Agriculture and Veterinary Medicine, An-Najah National University, Nablus, Palestine.
Introduction: Peste des petits ruminants (PPR) is a highly contagious and fatal disease affecting small ruminants, particularly goats and sheep, and is caused by Morbillivirus caprinae, a virus in the genus Morbillivirus, family Paramyxoviridae. PPR has significant economic and social impacts, especially in Africa, Asia, and the Middle East, where small ruminants are vital to rural livelihoods and food security. This disease is a priority for global eradication due to its disproportionate impact on low-income farmers and wildlife conservation.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!